Biodefense refers to the methods of restoring biosecurity in the body that is or can be exposed to biological threats or contagious illnesses that can possibly spread all around the world. Its scope also includes the detection and prevention of biological attacks.
It is believed the United States government has allocated an undetermined amount from the national fund gathered from taxpayers for various biodefense projects. However, arguably these funds are not enough to sustain and maintain many of the biodefense projects in the works. If they were continued, these projects would have been the protection people would need in defending bioterrorism—a layer of defense against the hazards of biological agents containing highly contagious diseases. For billionaire and philanthropist Bill Gates, he warns no one is ready, and the lack of biodefense is worrisome.
In one of the panels at the Munich Security Conference conducted February 17–19, 2017, the Microsoft co-founder spoke and admonished global leaders about the next global epidemic having a strong chance of coming from a computer screen.
Gates’ worries echoed those of biodefense companies. Leaders and investors are urged to invest and support biodefense companies by allocating more funds and biodefense stocks, respectively. It’s not just about profit: helping develop the necessary products to combat the biological threats may just save lives in the near future. Take a look at these three biosecurity companies that can change the biodefense game:
PharmAthene, Inc. (NYSEMKT:PIP)
PharmAthene, a company that develops “medical countermeasures against biological and chemical risks,” is creating a next-generation anthrax vaccine. Despite its shares rating being downgraded by TheStreet, Community Financial News reports that the company is optimistic about its stocks growing in short interest. This is due to the anthrax vaccine becoming a necessity amid bioterrorism threats and the possibility of a global pandemic just on the horizon.
Northrop Grumman Corporation (NYSE:NOC)
Meanwhile, InvestorPlace notes that Northrop Grumman Corporation is currently enjoying its high stock price. In biodefense, the company seeks to provide more solutions for the enhancement of the national medical research. Northrop Grumman also aims to give advanced bioinformatics and system integration leadership and support to the global health community.
With biodefense stocks on the rise, it seems that not only is the biodefense industry making a comeback, it is also on its way to fortifying defenses and finding more measures and methods against bioterrorism attacks.
Here’s how small businesses can increase their user engagement on social media
Posting to social media is a great but even better is creating conversation.
New Lamborghini SC18 is one of a kind
Lamborghini's Squadra Corse skunkworks released a one-off SC18 based on the combined concepts of an undoubtedly wealthy client and Lamborghini...
An impending bull run: Binance CEO predicts Bitcoin may make a comeback soon
Binance CEO Changpeng Zhao recently said that a bull-run is apparent for the cryptocurrency market, and it may be coming...
Cryptocurrency attacks continue to increase
Despite the improvement of cryptocurrency platforms and exchanges, the industry is not foolproof. In fact, more attacks are happening as...
Stoking the fire: A brief history of Kevin Durant and Draymond Green’s feud
Durant and Green’s recent locker room feud is currently one of the biggest stories in the NBA, but where did...
Sponsored2 days ago
Harbinger Research Labels PotNetwork a ‘Strong Speculative Buy’
Featured4 days ago
Business MOOCs: Where to learn and their impact in one’s career
Featured3 days ago
World leaders and their famous animal companions
Agriculture4 days ago
Cage-free eggs vs regular eggs: Which is better?
Business3 days ago
Tips on how to smartly use credit cards overseas
Featured5 days ago
Retirement planning: What to know about the current distribution phase
Business4 days ago
Why big data is a game changer for the real estate industry?
Business2 days ago
For the cannabis industry, big data is the new gold